Page last updated: 2024-11-04

rofecoxib and Alkalosis

rofecoxib has been researched along with Alkalosis in 1 studies

Alkalosis: A pathological condition that removes acid or adds base to the body fluids.

Research Excerpts

ExcerptRelevanceReference
"Gitelman's syndrome is manifested by hypokalemic alkalosis, hypomagnesemia, hypocalciuria, normotensive hyperreninemia and hyperaldosteronism."1.31Successful treatment by cyclooxyenase-2 inhibitor of refractory hypokalemia in a patient with Gitelman's syndrome. ( Farfel, Z; Gurevitz, O; Mayan, H, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mayan, H1
Gurevitz, O1
Farfel, Z1

Other Studies

1 other study available for rofecoxib and Alkalosis

ArticleYear
Successful treatment by cyclooxyenase-2 inhibitor of refractory hypokalemia in a patient with Gitelman's syndrome.
    Clinical nephrology, 2002, Volume: 58, Issue:1

    Topics: Adult; Alkalosis; Calcium; Cyclooxygenase Inhibitors; Humans; Hyperaldosteronism; Hypokalemia; Lacto

2002